Biotage AB (publ) (OM:BIOT) entered into an agreement to acquire ProMetic BioSciences Ltd. from Gamma Biosciences GP LLC for approximately $240 million on February 15, 2023. The transaction is conditional upon Biotage's shareholder approval and subject to customary closing conditions. Matthias Pannier, Karl Klackenberg, Linus Adolfsson, Sebastian Saadieh, Elis Allmark, Dain Hård Nevonen, William Kåge, Joel Magnusson, Anna Svensson, Gabriel Chabo, Sebastian Örndahl (Anti-trust), Sara Dahlros Sköld and Julia Hagelberg of Vinge acted as legal advisor to Biotage AB (publ) (OM:BIOT). Robert Moore and Martyn Jones of Herbert Smith Freehills LLP acted as legal advisor to Biotage AB (publ) (OM:BIOT). Wim De Vlieger of Gibson, Dunn & Crutcher UK LLP acted as legal advisor to Gamma Biosciences GP LLC.

Biotage AB (publ) (OM:BIOT) completed the acquisition of ProMetic BioSciences Ltd. from Gamma Biosciences GP LLC on June 1, 2023.